SFM
KYMR icon

Sphera Funds Management’s Kymera Therapeutics KYMR Stock Holding History

Sphera Funds Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-368,061
Closed -$15.6M – 69
2022
Q1 		$15.6M Buy
368,061
+49,394
+16% +$2.09M 2.61% 15
2021
Q4 		$20.2M Sell
318,667
-40,593
-11% -$2.36M 2.4% 11
2021
Q3 		$21.1M Buy
359,260
+99,365
+38% +$5.76M 2.09% 11
2021
Q2 		$12.6M Buy
259,895
+12,368
+5% +$537K 1.14% 33
2021
Q1 		$9.62M Buy
247,527
+99,827
+68% +$6.01M 0.88% 31
2020
Q4 		$9.16M Sell
147,700
-12,300
-8% -$600K 0.95% 35
2020
Q3 		$5.17M Buy
+160,000
New +$4.88M 0.6% 59

Other funds holding KYMR

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return